WFA Asset Management’s GSK GSK Stock Holding History

WFA Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$30.2K	Buy	740 +7	+1%	+$273	0.02%	126
2025 Q2	$28.2K	Buy	733 +8	+1%	+$306	0.02%	127
2025 Q1	$31.1K	Sell	725 -22	-3%	-$805	0.02%	132
2024 Q4	$25.3K	Buy	747 +7	+0.9%	+$252	0.01%	149
2024 Q3	$30.2K	Buy	740 +7	+1%	+$286	0.02%	127
2024 Q2	$28.2K	Buy	733 +8	+1%	+$337	0.02%	128
2024 Q1	$31.1K	Buy	725 +6	+0.8%	+$247	0.02%	133
2023 Q4	$26.6K	Hold	719	–	–	0.01%	130
2023 Q3	$26.1K	Hold	719	–	–	0.02%	128
2023 Q2	$25.6K	Buy	719 +165	+30%	+$5.92K	0.02%	136
2023 Q1	$19.7K	Hold	554	–	–	0.01%	143
2022 Q4	$19.5K	Hold	554	–	–	0.01%	127
2022 Q3	$16.3K	Buy	554 +4	+0.7%	+$152	0.01%	133
2022 Q2	$29.9K	Buy	550 +7	+1%	+$386	0.02%	108
2022 Q1	$29.6K	Buy	543 +6	+1%	+$326	0.02%	113
2021 Q4	$29.6K	Buy	+537	New	+$27.9K	0.02%	107

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WFA Asset Management's GSK Position: Q3 2025 in Review

WFA Asset Management increased its GSK (GSK) stake by 0.95% in Q3 2025, buying an estimated $273 and bringing the position to 740 shares worth $30.2K. The position accounts for 0.02% of the portfolio, ranked #126.

WFA Asset Management first reported a position in GSK in Q4 2021 and has held it in 16 quarters since. The position peaked at $31.1K in Q1 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

WFA Asset Management held 740 shares of GSK worth $30.2K as of Q3 2025.
WFA Asset Management bought 7 GSK shares in Q3 2025, an estimated $273.
GSK made up 0.02% of WFA Asset Management's portfolio in Q3 2025, its #126 holding.
WFA Asset Management first reported a position in GSK in Q4 2021 and has held it in 16 quarters since.
WFA Asset Management's GSK position peaked at $31.1K in Q1 2025.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.